New blood tests aim to make hemophilia treatment safer and more effective

NCT ID NCT02453542

Recruiting now Knowledge-focused Sponsor: Karolinska Institutet Source: ClinicalTrials.gov ↗

First seen Sep 30, 2025 · Last updated May 23, 2026 · Updated 26 times

Summary

This study looks at new blood tests to see if they can better measure how well bleeding treatments work in people with hemophilia who have developed inhibitors (antibodies that block standard treatment). Researchers will collect blood samples from 20 patients before and after they receive special bypassing medications. The goal is to improve monitoring, making treatment safer and more effective.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMOPHILIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Karolinska University Hospital
RECRUITING

Solna, Stockholm County, 17176, Sweden

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HEMOPHILIA